Twenty-five years in retina
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...
Childhood glaucoma
When a child is given a diagnosis of glaucoma, the impact upon that child and their family is enormous; equivalent to the diagnosis of a cancer [14]. This article outlines the knowledge, techniques and approaches that offer solutions to the...
Advances and developments in medical retina
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...
Paediatric ptosis
Manoj Parulekar and colleagues provide a comprehensive overview of the diagnosis, assessment and management of childhood ptosis. Blepharoptosis (commonly referred to as ptosis – Greek, πτῶσις, ‘to fall’) is a condition where the upper eyelid is in an abnormally low...
Simulated intravitreal injection training – the way forward
1 December 2018
| Niamh Stone, Srilakshmi Sharma
|
EYE - Vitreo-Retinal
Simulated surgical training is now recommended in the training curricula of all ophthalmologists in the United Kingdom [1]. Simulated training allows for familiarisation with a procedure, exercises the discipline of repetition, allows the resolution of technical difficulties and enables refinement...
Eye disease patients have more opportunity than ever to take part in NHS research studies
1 November 2018
|
EYE - General
A new report highlights how 76% of UK hospitals now offer patients the opportunity to take part in studies of eye disease to improve research and innovation. ‘Ophthalmology research in the UK’s National Health Service: the structure and performance of...
Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies
1 October 2018
| Rod McNeil
|
EYE - General
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...
Cataract incidence rates in patients from the UK suffering with diabetes mellitus
1 October 2018
| Rupert Bourne (Prof), Clare Bailey
|
EYE - Cataract, EYE - Refractive, EYE - General
The authors summarise the main findings from a recent study which investigated the incidence rates of cataract in patients with or without diabetes mellitus (DM). Background to the study Worldwide, the World Health Organization (WHO) estimates that 253 million people...
A short survey of the views of clinicians on the role of procedure-specific consent forms
1 October 2018
| Hamza Zafar, SZ Tan, SJ Charles, Niall Patton, A Jalil, G Turner, Rita McLauchlan, D Park, FD Scala
|
EYE - General
Informed consent is an ethical and legal right of every patient [1]. It is essential that patients receive clear, concise and accurate information regarding the risks, benefits and alternatives to a potential intervention. In addition to this, the patient must...
Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions
1 August 2018
| Rod McNeil
|
EYE - General
Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...
Isolated trochlear (fourth cranial) nerve palsy in an Asian population
1 August 2018
| Lakana Kumar Thavaratnam, James F (Barry) Cullen
|
EYE - Neuro-ophthalmology
The authors report on 35 consecutive new cases of isolated fourth cranial nerve palsy seen over a period of six months in one neuro-ophthalmology clinic in Southeast Asia, with emphasis on their aetiology and management. We report on 35 patients...
Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital
The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...
